Role of TNFα in bryostatin-induced inhibition of human hematopoiesis

被引:3
作者
Dräger, AM [1 ]
van der Hem, KG [1 ]
Zevenbergen, A [1 ]
Odding, JH [1 ]
Huijgens, PC [1 ]
Schuurhuis, GJ [1 ]
机构
[1] Vrije Univ Amsterdam, Univ Hosp, Dept Hematol, NL-1081 HV Amsterdam, Netherlands
关键词
bryostatin-1; TNF alpha; clonogenic cell growth; monocytes; CD34(+) cells;
D O I
10.1038/sj.leu.2401250
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In previous studies bryostatin has been shown to cause dose-dependent stimulatory or inhibitory effects on colony formation in acute myeloid leukemias. In this study we investigated the inhibitory effect of high dose bryostatin-1 (bryo-1) on normal human bone marrow mononuclear cells (BMNC) colony-forming capacity. Preculturing BMNC for 24 h with 250 nln bryo-1 reduced colony formation by 66 +/- 11% whereas this treatment did not reduce clonogenic capacity of highly purified CD34(+) BMNC. When precultures with bryo-1 were performed in the presence of several cytokine neutralizing antibodies abrogation of the inhibitory effect could only be demonstrated by anti-TNF alpha. However, preculturing of BMNC or CD34(+) cells with a wide range of TNF alpha concentrations as well as TNF alpha neutralization in supernatant of bryo-1-stimulated BMNC failed to affect the inhibitory effect on CD34(+) cells. Both indicate that TNF alpha was not the only factor responsible for the inhibitory effect. Depletion of CD14(+) cells from BMNC cultures showed that upon bryo-1 exposure the monocytes served as the main source of TNF alpha but not as a source of the inhibitory cytokine(s): in CD14(+)-depleted cultures the combination of exogenous added TNF alpha and bryo-1 resulted in an inhibition of colony formation comparable to that found in crude BMNC. In contrast, purified CD34(+) cultures were not directly affected by bryo-1 and TNF alpha. However, clonogenic growth of purified CD34(+) cells was inhibited if mononuclear cells were preincubated with TNF alpha alone for 24 h, and the supernatant of these cultures was used together with bryo-1. These results shaw that bryo-1-induced inhibition of clonogenic cell growth is not mediated by a direct effect of bryo-1 on CD34 cells but is a result of a process involving production of TNF alpha by CD14(+) cells upon bryo-1: stimulation together with the induction of (a) secondary factor(s) by TNF alpha, which together with bryo-1 itself is inhibitory towards clonogenic cell growth.
引用
收藏
页码:62 / 69
页数:8
相关论文
共 31 条
  • [1] BRACH MA, 1992, CANCER RES, V52, P2197
  • [2] BRAILLY H, 1993, LEUKEMIA, V7, P1557
  • [3] BROXMEYER HE, 1993, J IMMUNOL, V150, P3448
  • [4] DONNELLY RP, 1995, J IMMUNOL, V155, P1420
  • [5] TUMOR-NECROSIS-FACTOR DOWN-REGULATES GRANULOCYTE-COLONY-STIMULATING FACTOR RECEPTOR EXPRESSION ON HUMAN ACUTE MYELOID-LEUKEMIA CELLS AND GRANULOCYTES
    ELBAZ, O
    BUDEL, LM
    HOOGERBRUGGE, H
    TOUW, IP
    DELWEL, R
    MAHMOUD, LA
    LOWENBERG, B
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (03) : 838 - 841
  • [6] HAHN T, 1994, EXP HEMATOL, V22, P114
  • [7] HEYWORTH CM, 1993, BLOOD, V81, P894
  • [8] A PHASE-I TRIAL OF BRYOSTATIN 1 IN PATIENTS WITH ADVANCED MALIGNANCY USING A 24-HOUR INTRAVENOUS-INFUSION
    JAYSON, GC
    CROWTHER, D
    PRENDIVILLE, J
    MCGOWN, AT
    SCHEID, C
    STERN, P
    YOUNG, R
    BRENCHLEY, P
    CHANG, J
    OWENS, S
    PETTIT, GR
    [J]. BRITISH JOURNAL OF CANCER, 1995, 72 (02) : 461 - 468
  • [9] JONES RJ, 1990, BLOOD, V75, P1319
  • [10] KHOURY E, 1994, BLOOD, V84, P2506